0 XP   0   0   0

Panacea Biotec Limited
Buy, Hold or Sell?

Should you buy, hold or sell Panacea Biotec Limited?

I guess you are interested in Panacea Biotec Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Panacea Biotec Limited

Let's start. I'm going to help you getting a better view of Panacea Biotec Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Panacea Biotec Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Panacea Biotec Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Panacea Biotec Limited. The closing price on 2023-01-27 was INR127.50 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Panacea Biotec Limited Daily Candlestick Chart
Panacea Biotec Limited Daily Candlestick Chart
Summary









1. Valuation of Panacea Biotec Limited




Current price per share

INR127.50

2. Growth of Panacea Biotec Limited




Is Panacea Biotec Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$104.4m-$28.1m$132.5m126.9%

How much money is Panacea Biotec Limited making?

Current yearPrevious yearGrowGrow %
Making money$132.5m-$18.1m$150.7m113.7%
Net Profit Margin163.0%-23.6%--

How much money comes from the company's main activities?

3. Financial Health of Panacea Biotec Limited




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  


Richest
#37 / 1232

Most Revenue
#19 / 1232

Most Profit
#7 / 1232

Most Efficient
#38 / 1232


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of Panacea Biotec Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Panacea Biotec Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Panacea Biotec Limited to the Biotechnology industry mean.
  • A Net Profit Margin of 163.0% means that ₹1.63 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Panacea Biotec Limited:

  • The MRQ is 163.0%. The company is making a huge profit. +2
  • The TTM is 163.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ163.0%TTM163.0%0.0%
TTM163.0%YOY-23.6%+186.7%
TTM163.0%5Y19.9%+143.1%
5Y19.9%10Y5.5%+14.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ163.0%-223.6%+386.6%
TTM163.0%-281.7%+444.7%
YOY-23.6%-344.8%+321.2%
5Y19.9%-450.1%+470.0%
10Y5.5%-541.0%+546.5%
1.1.2. Return on Assets

Shows how efficient Panacea Biotec Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Panacea Biotec Limited to the Biotechnology industry mean.
  • 60.5% Return on Assets means that Panacea Biotec Limited generated ₹0.60 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Panacea Biotec Limited:

  • The MRQ is 60.5%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 60.5%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ60.5%TTM60.5%0.0%
TTM60.5%YOY-12.5%+73.0%
TTM60.5%5Y6.4%+54.1%
5Y6.4%10Y1.9%+4.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ60.5%-9.9%+70.4%
TTM60.5%-8.9%+69.4%
YOY-12.5%-9.3%-3.2%
5Y6.4%-11.7%+18.1%
10Y1.9%-12.7%+14.6%
1.1.3. Return on Equity

Shows how efficient Panacea Biotec Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Panacea Biotec Limited to the Biotechnology industry mean.
  • 127.0% Return on Equity means Panacea Biotec Limited generated ₹1.27 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Panacea Biotec Limited:

  • The MRQ is 127.0%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 127.0%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ127.0%TTM127.0%0.0%
TTM127.0%YOY-+127.0%
TTM127.0%5Y3.2%+123.8%
5Y3.2%10Y-5.5%+8.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ127.0%-12.0%+139.0%
TTM127.0%-11.5%+138.5%
YOY--10.8%+10.8%
5Y3.2%-14.2%+17.4%
10Y-5.5%-15.2%+9.7%

1.2. Operating Efficiency of Panacea Biotec Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Panacea Biotec Limited is operating .

  • Measures how much profit Panacea Biotec Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Panacea Biotec Limited to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Panacea Biotec Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y11.2%-11.2%
5Y11.2%10Y5.9%+5.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM--271.0%+271.0%
YOY--325.9%+325.9%
5Y11.2%-454.0%+465.2%
10Y5.9%-537.1%+543.0%
1.2.2. Operating Ratio

Measures how efficient Panacea Biotec Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.51 means that the operating costs are ₹0.51 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Panacea Biotec Limited:

  • The MRQ is 0.511. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.511. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.511TTM0.5110.000
TTM0.511YOY0.415+0.096
TTM0.5115Y0.856-0.346
5Y0.85610Y1.118-0.262
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5112.871-2.360
TTM0.5113.504-2.993
YOY0.4153.604-3.189
5Y0.8565.132-4.276
10Y1.1186.371-5.253

1.3. Liquidity of Panacea Biotec Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Panacea Biotec Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.30 means the company has ₹1.30 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Panacea Biotec Limited:

  • The MRQ is 1.296. The company is just able to pay all its short-term debts.
  • The TTM is 1.296. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.296TTM1.2960.000
TTM1.296YOY1.138+0.158
TTM1.2965Y0.930+0.366
5Y0.93010Y0.893+0.037
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2965.117-3.821
TTM1.2965.755-4.459
YOY1.1385.854-4.716
5Y0.9306.511-5.581
10Y0.8936.222-5.329
1.3.2. Quick Ratio

Measures if Panacea Biotec Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Panacea Biotec Limited to the Biotechnology industry mean.
  • A Quick Ratio of 1.57 means the company can pay off ₹1.57 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Panacea Biotec Limited:

  • The MRQ is 1.571. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.571. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.571TTM1.5710.000
TTM1.571YOY0.548+1.023
TTM1.5715Y0.600+0.971
5Y0.60010Y0.418+0.182
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5714.284-2.713
TTM1.5714.664-3.093
YOY0.5484.787-4.239
5Y0.6005.218-4.618
10Y0.4185.182-4.764

1.4. Solvency of Panacea Biotec Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Panacea Biotec Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Panacea Biotec Limited to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.52 means that Panacea Biotec Limited assets are financed with 52.4% credit (debt) and the remaining percentage (100% - 52.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Panacea Biotec Limited:

  • The MRQ is 0.524. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.524. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.524TTM0.5240.000
TTM0.524YOY1.194-0.670
TTM0.5245Y0.826-0.302
5Y0.82610Y0.799+0.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5240.278+0.246
TTM0.5240.277+0.247
YOY1.1940.306+0.888
5Y0.8260.367+0.459
10Y0.7990.403+0.396
1.4.2. Debt to Equity Ratio

Measures if Panacea Biotec Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Panacea Biotec Limited to the Biotechnology industry mean.
  • A Debt to Equity ratio of 110.0% means that company has ₹1.10 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Panacea Biotec Limited:

  • The MRQ is 1.100. The company is able to pay all its debts with equity. +1
  • The TTM is 1.100. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.100TTM1.1000.000
TTM1.100YOY-+1.100
TTM1.1005Y2.845-1.745
5Y2.84510Y3.082-0.236
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1000.315+0.785
TTM1.1000.317+0.783
YOY-0.319-0.319
5Y2.8450.403+2.442
10Y3.0820.462+2.620

2. Market Valuation of Panacea Biotec Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Panacea Biotec Limited generates.

  • Above 15 is considered overpriced but always compare Panacea Biotec Limited to the Biotechnology industry mean.
  • A PE ratio of 0.84 means the investor is paying ₹0.84 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Panacea Biotec Limited:

  • The EOD is 0.725. Very good. +2
  • The MRQ is 0.842. Very good. +2
  • The TTM is 0.842. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.725MRQ0.842-0.118
MRQ0.842TTM0.8420.000
TTM0.842YOY-7.357+8.199
TTM0.8425Y0.019+0.823
5Y0.01910Y-6.921+6.940
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.725-8.986+9.711
MRQ0.842-9.792+10.634
TTM0.842-16.243+17.085
YOY-7.357-20.876+13.519
5Y0.019-16.665+16.684
10Y-6.921-14.732+7.811
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Panacea Biotec Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Panacea Biotec Limited:

  • The MRQ is 0.091. Very good. +2
  • The TTM is 0.091. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.091TTM0.0910.000
TTM0.091YOY-5.934+6.025
TTM0.0915Y-5.358+5.448
5Y-5.35810Y-4.126-1.232
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.091-0.032+0.123
TTM0.0910.004+0.087
YOY-5.9340.016-5.950
5Y-5.3580.006-5.364
10Y-4.1260.003-4.129

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Panacea Biotec Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.07 means the investor is paying ₹1.07 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Panacea Biotec Limited:

  • The EOD is 0.920. Very good. +2
  • The MRQ is 1.070. Good. +1
  • The TTM is 1.070. Good. +1
Trends
Current periodCompared to+/- 
EOD0.920MRQ1.070-0.150
MRQ1.070TTM1.0700.000
TTM1.070YOY-4.751+5.821
TTM1.0705Y1.691-0.622
5Y1.69110Y1.729-0.038
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.9201.835-0.915
MRQ1.0702.006-0.936
TTM1.0702.774-1.704
YOY-4.7513.453-8.204
5Y1.6912.713-1.022
10Y1.7292.402-0.673
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Panacea Biotec Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--175.914175.9140%-69.792+140%16.102+993%15.397+1042%
Book Value Growth--5.7115.7110%-1.150+120%1.426+300%1.222+367%
Book Value Per Share--138.577138.5770%-37.337+127%48.260+187%58.596+136%
Book Value Per Share Growth--5.7115.7110%-1.150+120%1.426+300%1.222+367%
Current Ratio--1.2961.2960%1.138+14%0.930+39%0.893+45%
Debt To Asset Ratio--0.5240.5240%1.194-56%0.826-37%0.799-34%
Debt To Equity Ratio--1.1001.1000%-+100%2.845-61%3.082-64%
Dividend Per Share----0%-0%-0%-0%
Eps--175.979175.9790%-24.113+114%22.846+670%7.406+2276%
Eps Growth--9.2989.2980%1.240+650%1.708+444%1.305+612%
Free Cash Flow Per Share---19.746-19.7460%13.859-242%4.224-568%6.216-418%
Free Cash Flow Per Share Growth---1.425-1.4250%4.286-133%0.884-261%2.956-148%
Free Cash Flow To Equity Per Share---211.720-211.7200%6.168-3533%-41.415-80%-23.770-89%
Free Cash Flow To Equity Per Share Growth---34.328-34.3280%0.705-4971%-64.056+87%-39.591+15%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--7296.023--------
Intrinsic Value_10Y_min--6007.893--------
Intrinsic Value_1Y_max--142.453--------
Intrinsic Value_1Y_min--138.421--------
Intrinsic Value_3Y_max--876.641--------
Intrinsic Value_3Y_min--819.909--------
Intrinsic Value_5Y_max--2151.702--------
Intrinsic Value_5Y_min--1938.950--------
Net Profit Margin--1.6301.6300%-0.236+115%0.199+719%0.055+2866%
Operating Margin----0%-0%0.112-100%0.059-100%
Operating Ratio--0.5110.5110%0.415+23%0.856-40%1.118-54%
Pb Ratio0.920-16%1.0701.0700%-4.751+544%1.691-37%1.729-38%
Pe Ratio0.725-16%0.8420.8420%-7.357+973%0.019+4268%-6.921+922%
Peg Ratio--0.0910.0910%-5.934+6650%-5.358+6013%-4.126+4653%
Price Per Share127.500-16%148.250148.2500%177.400-16%180.090-18%154.328-4%
Price To Total Gains Ratio0.725-16%0.8430.8430%-2.542+402%-2.367+381%-6.554+878%
Profit Growth--9.2989.2980%1.240+650%1.708+444%1.305+612%
Quick Ratio--1.5711.5710%0.548+187%0.600+162%0.418+276%
Return On Assets--0.6050.6050%-0.125+121%0.064+842%0.019+3146%
Return On Equity--1.2701.2700%-+100%0.032+3851%-0.055+104%
Revenue Growth--1.0581.0580%1.148-8%1.047+1%1.048+1%
Total Gains Per Share--175.914175.9140%-69.792+140%16.102+993%15.397+1042%
Total Gains Per Share Growth--4.5214.5210%-0.820+118%0.795+469%0.697+548%
Usd Book Value--104401416.000104401416.0000%-28129239.000+127%36358086.600+187%44145014.333+136%
Usd Book Value Change Per Share--2.1642.1640%-0.858+140%0.198+993%0.189+1042%
Usd Book Value Per Share--1.7041.7040%-0.459+127%0.594+187%0.721+136%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--2.1652.1650%-0.297+114%0.281+670%0.091+2276%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share---0.243-0.2430%0.170-242%0.052-568%0.076-418%
Usd Free Cash Flow To Equity Per Share---2.604-2.6040%0.076-3533%-0.509-80%-0.292-89%
Usd Price Per Share1.568-16%1.8231.8230%2.182-16%2.215-18%1.898-4%
Usd Profit--132579855.000132579855.0000%-18166608.000+114%17212078.800+670%5579744.667+2276%
Usd Revenue--81331536.00081331536.0000%76851015.000+6%70920668.400+15%72312588.333+12%
Usd Total Gains Per Share--2.1642.1640%-0.858+140%0.198+993%0.189+1042%
 EOD+3 -2MRQTTM+0 -0YOY+24 -135Y+29 -910Y+29 -9

3.2. Fundamental Score

Let's check the fundamental score of Panacea Biotec Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.725
Price to Book Ratio (EOD)Between0-10.920
Net Profit Margin (MRQ)Greater than01.630
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.571
Current Ratio (MRQ)Greater than11.296
Debt to Asset Ratio (MRQ)Less than10.524
Debt to Equity Ratio (MRQ)Less than11.100
Return on Equity (MRQ)Greater than0.151.270
Return on Assets (MRQ)Greater than0.050.605
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Panacea Biotec Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose129.400
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets17,825,050
Total Liabilities9,337,130
Total Stockholder Equity8,487,920
 As reported
Total Liabilities 9,337,130
Total Stockholder Equity+ 8,487,920
Total Assets = 17,825,050

Assets

Total Assets17,825,050
Total Current Assets10,405,500
Long-term Assets10,405,500
Total Current Assets
Cash And Cash Equivalents 478,000
Short-term Investments 5,396,760
Net Receivables 1,316,560
Inventory 2,190,220
Other Current Assets 919,990
Total Current Assets  (as reported)10,405,500
Total Current Assets  (calculated)10,301,530
+/- 103,970
Long-term Assets
Property Plant Equipment 5,927,190
Intangible Assets 138,240
Long-term Assets  (as reported)0
Long-term Assets  (calculated)6,065,430
+/- 6,065,430

Liabilities & Shareholders' Equity

Total Current Liabilities8,027,680
Long-term Liabilities-
Total Stockholder Equity8,487,920
Total Current Liabilities
Total Current Liabilities  (as reported)8,027,680
Total Current Liabilities  (calculated)0
+/- 8,027,680
Long-term Liabilities
Long term Debt Total 341,030
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)341,030
+/- 341,030
Total Stockholder Equity
Common Stock61,250
Retained Earnings 7,467,000
Capital Surplus 919,400
Other Stockholders Equity 40,270
Total Stockholder Equity (as reported)8,487,920
Total Stockholder Equity (calculated)8,487,920
+/-0
Other
Cash And Equivalents25,500
Cash and Short Term Investments 5,900,260
Common Stock Shares Outstanding 61,251
Liabilities and Stockholders Equity 17,825,050



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
19,433,500
19,304,700
18,029,880
18,001,380
16,075,560
13,755,200
13,903,000
11,775,320
17,825,050
17,825,05011,775,32013,903,00013,755,20016,075,56018,001,38018,029,88019,304,70019,433,500
   > Total Current Assets 
3,728,100
5,257,200
6,637,430
6,997,250
5,603,460
5,078,860
3,595,000
5,109,720
10,405,500
10,405,5005,109,7203,595,0005,078,8605,603,4606,997,2506,637,4305,257,2003,728,100
       Cash And Cash Equivalents 
247,800
524,000
229,300
239,000
164,370
144,660
402,200
520,790
478,000
478,000520,790402,200144,660164,370239,000229,300524,000247,800
       Short-term Investments 
0
49,800
35,200
2,700
20,290
90,140
495,330
129,070
5,396,760
5,396,760129,070495,33090,14020,2902,70035,20049,8000
       Net Receivables 
1,010,100
1,053,300
1,233,710
1,421,710
1,360,100
887,300
685,200
846,840
1,316,560
1,316,560846,840685,200887,3001,360,1001,421,7101,233,7101,053,3001,010,100
       Inventory 
2,198,100
3,102,200
3,075,330
3,155,540
3,342,060
814,270
1,476,900
1,741,370
2,190,220
2,190,2201,741,3701,476,900814,2703,342,0603,155,5403,075,3303,102,2002,198,100
       Other Current Assets 
227,600
497,500
1,748,750
1,739,120
141,210
2,756,390
429,100
1,014,560
919,990
919,9901,014,560429,1002,756,390141,2101,739,1201,748,750497,500227,600
   > Long-term Assets 
0
0
0
12,513,900
10,472,100
8,676,340
0
0
0
0008,676,34010,472,10012,513,900000
       Property Plant Equipment 
13,983,100
12,597,200
10,512,110
10,023,200
9,503,950
8,115,000
6,650,300
6,278,940
5,927,190
5,927,1906,278,9406,650,3008,115,0009,503,95010,023,20010,512,11012,597,20013,983,100
       Goodwill 
53,100
67,200
8,960
8,960
8,960
0
0
0
0
00008,9608,9608,96067,20053,100
       Long Term Investments 
163,200
102,800
57,500
21,100
0
0
0
0
0
0000021,10057,500102,800163,200
       Intangible Assets 
195,400
168,100
230,110
285,640
376,050
165,700
163,600
152,210
138,240
138,240152,210163,600165,700376,050285,640230,110168,100195,400
       Long-term Assets Other 
0
0
0
1,700
40,280
97,980
0
0
0
00097,98040,2801,700000
> Total Liabilities 
14,251,500
14,557,600
13,994,210
14,444,630
12,988,710
10,251,230
11,915,100
14,062,250
9,337,130
9,337,13014,062,25011,915,10010,251,23012,988,71014,444,63013,994,21014,557,60014,251,500
   > Total Current Liabilities 
8,268,200
7,060,300
5,671,710
6,856,420
6,910,240
9,382,610
4,167,600
4,490,910
8,027,680
8,027,6804,490,9104,167,6009,382,6106,910,2406,856,4205,671,7107,060,3008,268,200
       Short-term Debt 
10,609,400
11,087,800
1,893,180
1,907,120
1,648,800
693,850
35,700
844,460
0
0844,46035,700693,8501,648,8001,907,1201,893,18011,087,80010,609,400
       Short Long Term Debt 
10,609,400
11,087,800
11,362,000
11,487,600
3,700,380
6,003,730
0
0
0
0006,003,7303,700,38011,487,60011,362,00011,087,80010,609,400
       Accounts payable 
2,521,100
2,091,300
1,878,700
2,392,700
2,771,950
2,697,100
1,988,500
0
0
001,988,5002,697,1002,771,9502,392,7001,878,7002,091,3002,521,100
       Other Current Liabilities 
362,400
206,000
283,700
288,800
228,630
567,360
657,400
0
0
00657,400567,360228,630288,800283,700206,000362,400
   > Long-term Liabilities 
0
0
0
8,651,400
6,107,960
898,710
0
0
0
000898,7106,107,9608,651,400000
       Long term Debt Total 
0
0
7,857,110
7,140,610
5,707,080
461,220
6,131,300
7,350,800
341,030
341,0307,350,8006,131,300461,2205,707,0807,140,6107,857,11000
       Other Liabilities 
139,800
128,700
150,700
177,200
400,880
437,490
1,262,200
0
0
001,262,200437,490400,880177,200150,700128,700139,800
> Total Stockholder Equity
5,127,200
4,549,900
4,035,670
3,556,750
3,086,850
3,503,970
1,987,900
-2,286,930
8,487,920
8,487,920-2,286,9301,987,9003,503,9703,086,8503,556,7504,035,6704,549,9005,127,200
   Common Stock
61,300
61,300
61,250
61,250
61,250
61,250
61,300
61,250
61,250
61,25061,25061,30061,25061,25061,25061,25061,30061,300
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 
0
0
919,400
919,400
919,400
919,400
919,400
919,400
919,400
919,400919,400919,400919,400919,400919,400919,40000
   Treasury Stock000000000
   Other Stockholders Equity 
5,007,600
5,496,400
-207,700
-133,940
-1,010
45,450
1,926,600
43,280
40,270
40,27043,2801,926,60045,450-1,010-133,940-207,7005,496,4005,007,600



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue6,612,320
Cost of Revenue-3,378,300
Gross Profit3,234,0203,234,020
 
Operating Income (+$)
Gross Profit3,234,020
Operating Expense--
Operating Income16,220,1403,234,020
 
Operating Expense (+$)
Research Development-
Selling General Administrative3,267,070
Selling And Marketing Expenses-
Operating Expense-3,267,070
 
Net Interest Income (+$)
Interest Income1,760,480
Interest Expense--
Net Interest Income-1,760,480
 
Pretax Income (+$)
Operating Income16,220,140
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)14,488,09016,220,140
EBIT - interestExpense = 0
10,778,850
10,778,850
Interest Expense-
Earnings Before Interest and Taxes (ebit)-14,488,090
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax14,488,090
Tax Provision-3,709,050
Net Income From Continuing Ops-10,779,040
Net Income10,778,850
Net Income Applicable To Common Shares10,778,850
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items0
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
AW03.INDX
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AW03.INDX.

AW03.INDX Daily Candlestick Chart
IMXL.INDX
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IMXL.INDX.

IMXL.INDX Daily Candlestick Chart
MDAXI.INDX
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MDAXI.INDX.

MDAXI.INDX Daily Candlestick Chart
SXOOR.INDX
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SXOOR.INDX.

SXOOR.INDX Daily Candlestick Chart
SXOE.INDX
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SXOE.INDX.

SXOE.INDX Daily Candlestick Chart
ATDS.PINK
7 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of ATDS.PINK.

ATDS.PINK Daily Candlestick Chart
AMSA.PINK
10 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of AMSA.PINK.

AMSA.PINK Daily Candlestick Chart
CMBN.SW
15 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CMBN.SW.

CMBN.SW Daily Candlestick Chart
6MK.STU
17 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 6MK.STU.

6MK.STU Daily Candlestick Chart
GGRO.TO
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GGRO.TO.

GGRO.TO Daily Candlestick Chart
0RYA.IL
19 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0RYA.IL.

0RYA.IL Daily Candlestick Chart
USCU.V
19 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of USCU.V.

USCU.V Daily Candlestick Chart
CNE.TO
20 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CNE.TO.

CNE.TO Daily Candlestick Chart
BARU.V
21 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of BARU.V.

BARU.V Daily Candlestick Chart
ALVO.IC
29 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ALVO.IC.

ALVO.IC Daily Candlestick Chart
HURA.TO
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HURA.TO.

HURA.TO Daily Candlestick Chart
IGF.NASDAQ
31 minutes ago

I found you a Golden Cross on the daily chart of IGF.NASDAQ.

IGF.NASDAQ Daily Candlestick Chart
IGBH.NYSE ARC
31 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IGBH.NYSE ARC.

IGBH.NYSE ARC Daily Candlestick Chart
IFGL.NASDAQ
31 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IFGL.NASDAQ.

IFGL.NASDAQ Daily Candlestick Chart
IEMG.NYSE ARC
31 minutes ago

I found you a Golden Cross on the daily chart of IEMG.NYSE ARC.

IEMG.NYSE ARC Daily Candlestick Chart
IDRV.NYSE ARC
31 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IDRV.NYSE ARC.

IDRV.NYSE ARC Daily Candlestick Chart
KESAR.BSE
33 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of KESAR.BSE.

KESAR.BSE Daily Candlestick Chart
SGAMY.PINK
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGAMY.PINK.

SGAMY.PINK Daily Candlestick Chart
RUG.V
34 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of RUG.V.

RUG.V Daily Candlestick Chart
FLRK.LSE
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FLRK.LSE.

FLRK.LSE Daily Candlestick Chart